RenovaCare, Inc. Logo

RenovaCare, Inc.

RCAR

(1.8)
Stock Price

0,00 USD

-127.61% ROA

0% ROE

-0x PER

Market Cap.

87,00 USD

1.3% DER

0% Yield

0% NPM

RenovaCare, Inc. Stock Analysis

RenovaCare, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

RenovaCare, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (1%), which means it has a small amount of debt compared to the ownership it holds

3 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

4 Net Profit Growth

This company's net profit has been consistently on the rise over the past three years, indicating a strong financial performance and making it an appealing investment opportunity.

5 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

6 ROE

Negative ROE (-94.75%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

7 ROA

The stock's ROA (-127.61%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

RenovaCare, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

RenovaCare, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

RenovaCare, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

RenovaCare, Inc. Revenue
Year Revenue Growth
1998 66.426
1999 0 0%
2000 153.711 100%
2001 463.288 66.82%
2002 919.418 49.61%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 13.770 100%
2009 51.134 73.07%
2010 39.846 -28.33%
2011 32.787 -21.53%
2012 19.494 -68.19%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

RenovaCare, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1998 0
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 36.851 100%
2012 0 0%
2013 0 0%
2014 975.667 100%
2015 281.218 -246.94%
2016 309.503 9.14%
2017 574.091 46.09%
2018 368.954 -55.6%
2019 745.945 50.54%
2020 4.133.925 81.96%
2021 3.204.895 -28.99%
2022 1.552.328 -106.46%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

RenovaCare, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1998 0
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 47.684 100%
2007 7.950 -499.8%
2008 0 0%
2009 312.162 100%
2010 0 0%
2011 536.090 100%
2012 248.597 -115.65%
2013 628.545 60.45%
2014 1.155.729 45.61%
2015 1.037.289 -11.42%
2016 1.588.719 34.71%
2017 2.121.732 25.12%
2018 1.639.068 -29.45%
2019 2.944.377 44.33%
2020 5.543.173 46.88%
2021 2.204.521 -151.45%
2022 5.957.092 62.99%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

RenovaCare, Inc. EBITDA
Year EBITDA Growth
1998 -302.934
1999 -747.990 59.5%
2000 -491.975 -52.04%
2001 -183.207 -168.54%
2002 -152.605 -20.05%
2003 -579.713 73.68%
2004 -133.674 -333.68%
2005 -56.543 -136.41%
2006 -118.942 52.46%
2007 -27.610 -330.79%
2008 -186.003 85.16%
2009 -1.877.573 90.09%
2010 3.651.106 151.42%
2011 -6.039.516 160.45%
2012 -239.378 -2423%
2013 -628.545 61.92%
2014 -2.131.396 70.51%
2015 -1.318.507 -61.65%
2016 -1.897.135 30.5%
2017 -2.692.370 29.54%
2018 -1.985.255 -35.62%
2019 -3.357.818 40.88%
2020 -9.655.076 65.22%
2021 -5.400.048 -78.8%
2022 -1.515.040 -256.43%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

RenovaCare, Inc. Gross Profit
Year Gross Profit Growth
1998 66.426
1999 0 0%
2000 292.531 100%
2001 204.679 -42.92%
2002 693.064 70.47%
2003 0 0%
2004 0 0%
2005 -25.520 100%
2006 -56.546 54.87%
2007 -9.825 -475.53%
2008 4.690 309.49%
2009 8.150 42.45%
2010 14.858 45.15%
2011 -216.394 106.87%
2012 -12.893 -1578.38%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

RenovaCare, Inc. Net Profit
Year Net Profit Growth
1998 -231.877
1999 -709.659 67.33%
2000 -771.547 8.02%
2001 -317.965 -142.65%
2002 -262.401 -21.18%
2003 -699.823 62.5%
2004 -175.052 -299.78%
2005 -67.966 -157.56%
2006 -45.004 -51.02%
2007 -24.682 -82.34%
2008 -265.149 90.69%
2009 1.269.549 120.89%
2010 -4.266.626 129.76%
2011 4.457.582 195.72%
2012 -243.959 1927.18%
2013 -1.032.788 76.38%
2014 -2.131.396 51.54%
2015 -1.318.507 -61.65%
2016 -2.077.889 36.55%
2017 -3.689.338 43.68%
2018 -2.120.841 -73.96%
2019 -3.358.082 36.84%
2020 -9.419.574 64.35%
2021 -4.465.306 -110.95%
2022 4.314.120 203.5%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

RenovaCare, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1998 0
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

RenovaCare, Inc. Free Cashflow
Year Free Cashflow Growth
1998 -231.877
1999 -709.659 67.33%
2000 -684.331 -3.7%
2001 -71.544 -856.52%
2002 23.508 404.34%
2003 -538.392 104.37%
2004 -163.905 -228.48%
2005 -46.308 -253.95%
2006 -81.800 43.39%
2007 46.128 277.33%
2008 -511.715 109.01%
2009 -324.821 -57.54%
2010 -357.465 9.13%
2011 -1.267.807 71.8%
2012 -274.176 -362.41%
2013 -512.752 46.53%
2014 -825.745 37.9%
2015 -1.295.509 36.26%
2016 -1.789.559 27.61%
2017 -1.674.028 -6.9%
2018 -2.026.213 17.38%
2019 -3.212.276 36.92%
2020 -4.764.284 32.58%
2021 -4.563.777 -4.39%
2022 -148.218 -2979.1%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

RenovaCare, Inc. Operating Cashflow
Year Operating Cashflow Growth
1998 -231.877
1999 -709.659 67.33%
2000 -656.524 -8.09%
2001 -71.544 -817.65%
2002 131.131 154.56%
2003 -538.206 124.36%
2004 -135.564 -297.01%
2005 -46.308 -192.74%
2006 -81.800 43.39%
2007 46.128 277.33%
2008 -69.687 166.19%
2009 -290.976 76.05%
2010 -348.162 16.43%
2011 -747.458 53.42%
2012 -267.214 -179.72%
2013 -349.898 23.63%
2014 -825.745 57.63%
2015 -1.295.509 36.26%
2016 -1.788.608 27.57%
2017 -1.674.028 -6.84%
2018 -2.026.213 17.38%
2019 -3.212.276 36.92%
2020 -4.723.011 31.99%
2021 -4.563.777 -3.49%
2022 -148.218 -2979.1%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

RenovaCare, Inc. Capital Expenditure
Year Capital Expenditure Growth
1998 0
1999 0 0%
2000 27.807 100%
2001 0 0%
2002 107.623 100%
2003 186 -57761.83%
2004 28.341 99.34%
2005 0 0%
2006 0 0%
2007 0 0%
2008 442.028 100%
2009 33.845 -1206.04%
2010 9.303 -263.81%
2011 520.349 98.21%
2012 6.962 -7374.13%
2013 162.854 95.73%
2014 0 0%
2015 0 0%
2016 951 100%
2017 0 0%
2018 0 0%
2019 0 0%
2020 41.273 100%
2021 0 0%
2022 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

RenovaCare, Inc. Equity
Year Equity Growth
1998 1.216.048
1999 2.130.559 42.92%
2000 1.331.421 -60.02%
2001 1.013.456 -31.37%
2002 1.045.734 3.09%
2003 478.016 -118.77%
2004 429.127 -11.39%
2005 1.532.380 72%
2006 45.876 -3240.27%
2007 21.194 -116.46%
2008 3.025.216 99.3%
2009 1.061.004 -185.13%
2010 -3.241.760 132.73%
2011 1.211.718 367.53%
2012 967.759 -25.21%
2013 1.697.486 42.99%
2014 474.338 -257.86%
2015 224.953 -110.86%
2016 239.327 6.01%
2017 1.664.513 85.62%
2018 15.326.689 89.14%
2019 12.159.862 -26.04%
2020 7.078.775 -71.78%
2021 2.346.889 -201.62%
2022 -1.459.699 260.78%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

RenovaCare, Inc. Assets
Year Assets Growth
1998 1.233.862
1999 2.152.285 42.67%
2000 1.436.470 -49.83%
2001 1.204.250 -19.28%
2002 1.143.261 -5.33%
2003 513.147 -122.79%
2004 460.787 -11.36%
2005 1.571.528 70.68%
2006 84.266 -1764.96%
2007 46.306 -81.98%
2008 3.088.147 98.5%
2009 2.515.064 -22.79%
2010 2.081.513 -20.83%
2011 1.340.727 -55.25%
2012 1.065.834 -25.79%
2013 1.752.927 39.2%
2014 853.400 -105.41%
2015 560.736 -52.19%
2016 603.318 7.06%
2017 3.060.422 80.29%
2018 15.719.349 80.53%
2019 12.440.602 -26.36%
2020 8.395.944 -48.17%
2021 3.652.134 -129.89%
2022 1.055.374 -246.05%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

RenovaCare, Inc. Liabilities
Year Liabilities Growth
1998 20.000
1999 20.726 3.5%
2000 105.049 80.27%
2001 190.794 44.94%
2002 97.527 -95.63%
2003 35.131 -177.61%
2004 31.660 -10.96%
2005 39.148 19.13%
2006 38.390 -1.97%
2007 25.112 -52.88%
2008 62.931 60.1%
2009 1.454.060 95.67%
2010 5.323.273 72.68%
2011 129.009 -4026.28%
2012 98.075 -31.54%
2013 55.441 -76.9%
2014 379.062 85.37%
2015 335.783 -12.89%
2016 363.991 7.75%
2017 1.395.909 73.92%
2018 392.660 -255.5%
2019 280.740 -39.87%
2020 1.317.169 78.69%
2021 1.305.245 -0.91%
2022 2.515.073 48.1%

RenovaCare, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.05
Price to Earning Ratio
-0x
Price To Sales Ratio
0x
POCF Ratio
-0
PFCF Ratio
-0
Price to Book Ratio
0
EV to Sales
0
EV Over EBITDA
0.52
EV to Operating CashFlow
0.62
EV to FreeCashFlow
0.62
Earnings Yield
-51118.32
FreeCashFlow Yield
-52457.21
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.18
Graham NetNet
0.02

Income Statement Metrics

Net Income per Share
-0.05
Income Quality
1.02
ROE
-0.95
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0
EBT Per Ebit
0
Ebit per Revenue
0
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.05
Free CashFlow per Share
-0.05
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-2.24
Return on Tangible Assets
-1.28
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,03
Book Value per Share
0,03
Tangible Book Value per Share
0.03
Shareholders Equity per Share
0.03
Interest Debt per Share
0
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
0.52
Current Ratio
2.59
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0.01
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.04
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
350.54

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

RenovaCare, Inc. Dividends
Year Dividends Growth

RenovaCare, Inc. Profile

About RenovaCare, Inc.

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.

CEO
Mr. Harmel S. Rayat
Employee
1
Address
9375 East Shea Blvd
Scottsdale, 85260

RenovaCare, Inc. Executives & BODs

RenovaCare, Inc. Executives & BODs
# Name Age
1 Mr. Justin Frere CPA, M.B.A.
Treasurer
70
2 Dr. Robin A. Robinson Ph.D.
Chairman of Scientific Advisory Board, Vice President & Chief Scientific Officer
70
3 Mr. Harmel S. Rayat
President, Chief Executive Officer, Chief Financial Officer, Interim Secretary & Chairman of the Board
70
4 Dr. Jo Ellen Schweinle M.D.
Chief Medical Officer
70

RenovaCare, Inc. Competitors